title: A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
abstract: Zinc/clindamycin gel (Zindaclin 1%) gel, is a new once-daily topical acne treatment (Strakan Ltd) containing clindamycin phosphate equivalent to 1% clindamycin and zinc acetate in a formulation, which leads to a reduced systemic absorption of clindamycin through the skin. The objective of the study was to compare the systemic absorption of clindamycin from zinc/clindamycin gel and clindamycin lotion (Dalacin T topical lotion, Pharmacia Ltd) after repeated twice-daily topical administration for two periods of 5 days with an intervening gap of 2 weeks in 24 subjects with mild to moderate acne. Plasma Cmax, and AUC0-12 of clindamycin measured after single and multiple applications of zinc/clindamycin gel were between 30% and 50% lower than for clindamycin lotion. As zinc/clindamycin gel is a topical treatment for acne, the lower systemic bioavailability may be beneficial because there may be a correspondingly lower risk of systemic events in zinc/clindamycin gel-treated subjects.
authors.affiliation: Aster Cephac, Paris, FranceStrakan Ltd, Buckholm Mill, Galashiels, UK. dchassard@aster-cephac.com
authors.forename: Didier
authors.initials: D
authors.lastname: Chassard
authors.forename: Roo
authors.initials: R
authors.lastname: Kanis
authors.forename: Florence
authors.initials: F
authors.lastname: Namour
authors.forename: Eric
authors.initials: E
authors.lastname: Evene
authors.forename: Bernard
authors.initials: B
authors.lastname: Ntssikoussalabongui
authors.forename: Valérie
authors.initials: V
authors.lastname: Schmitz
mesh_terms: D000152:Acne Vulgaris / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D019540:Area Under Curve; D002981:Clindamycin / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D018592:Cross-Over Studies; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D012720:Severity of Illness Index; D012869:Skin Absorption; D016896:Treatment Outcome; D019345:Zinc Acetate / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D002981:Clindamycin; D019345:Zinc Acetate